Food and Drug Administration granted approval for Wegovy (semaglutide) injection at a 2.4 mg dosage, administered once weekly
Semaglutide injections have helped millions achieve sustained weight loss by reducing appetite and improving blood sugar control
doi: 10.1089/thy.2012.0548 81 LiuMSongJJiangYLiuYPengJLiangHet al
Although the economics of diabetes care is complex and broadly includes the costs to society of diabetic complications and long-term outcomes, the cost of drugs and the affordability of treatment are often the primary basis for decision making
In the last decades, IGF-1 has been implicated in many physiological actions, among others: tissue growth and development, proliferative, lipid metabolism, pro-survival/anti-aging, anti-inflammatory, anabolic, and antioxidant with neuro- and hepatoprotective properties [105116]
Additionally, the FDA continued its regulatory action against the sale/distribution of unapproved opioid products